Use of Xanthinol Nicotinate as a co-treatment for radio- and chemo-therapy in experimental tumors

2010 ◽  
Vol 126 (2) ◽  
pp. 583-588 ◽  
Author(s):  
Jérome Segers ◽  
Nathalie Crokart ◽  
Pierre Danhier ◽  
Vincent Grégoire ◽  
Bénédicte F. Jordan ◽  
...  
Keyword(s):  
Experimental Tumors ◽  
Xanthinol Nicotinate

57Co-Hematoporphyrin Accumulation by Experimental Tumors

1976 ◽  
Vol 15 (04) ◽  
pp. 183-184 ◽  
Author(s):  
L. J. Anghileri ◽  
M. Heidbreder ◽  
R. Mathes
Keyword(s):  
Experimental Tumors ◽  
Potential Value ◽  
Tumor Bearing ◽  
In Vivo Distribution

SummaryThe in vivo distribution of 57Co-hematoporphyrin in adenocarcinoma BW10232-bearing mice has been studied. Tumor-bearing and normal animals exhibit similar patterns of radioactivity accumulation. Twenty-four hours after the administration of the radiocompound the ratios tumor to blood and tumor to muscle indicate a potential value of this radioactive porphyrin for the detection of some types of tumor.

Effects of thymic factors on growth of experimental tumors

1980 ◽  
Vol 13 (4) ◽  
pp. 329-335 ◽  
Author(s):  
L. J. Anghileri ◽  
N. Kelemen ◽  
F. Lasmoles ◽  
J. N. Talbot ◽  
G. Milhaud
Keyword(s):  
Experimental Tumors

808 Induction of oxidative stress by the copper nanoparticles in experimental tumors

2015 ◽  
Vol 51 ◽  
pp. S135-S136
Author(s):  
P. Kachesova ◽  
I. Goroshinskaya ◽  
E. Shalashnaya ◽  
I. Neskubina ◽  
L. Vladimirova ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Copper Nanoparticles ◽  
Experimental Tumors

Pentoxifylline in Strokes: A Clinical Study

1980 ◽  
Vol 8 (1) ◽  
pp. 56-62 ◽  
Author(s):  
S Janaki
Keyword(s):  
Clinical Study ◽  
Motor Deficit ◽  
Cerebral Thrombosis ◽  
Memory Score ◽  
Comparative Clinical Study ◽  
Xanthinol Nicotinate

The results of a comparative clinical study with pentoxifylline – a new vasoactive compound – and xanthinol nicotinate in fifty-eight patients suffering from cerebral thrombosis with hemiplegia or monoplegia, are presented. Pentoxifylline appeared to be more effective in reducing motor deficit and was significantly better in improving the patients' intelligence and memory score. Recovery from speech deficit was equally well seen with both drugs.

Xenogenization of Experimental Tumors by Triazene Derivatives

Triazenes ◽  
1990 ◽  
pp. 79-89 ◽  
Author(s):  
Paolo Puccetti ◽  
Luigina Romani ◽  
Ursula Grohmann ◽  
Roberta Bianchi ◽  
Patrizia Fuschiotti ◽  
...  
Keyword(s):  
Experimental Tumors
Sign in / Sign up

Export Citation Format

Share Document